What is the diagnosis and treatment for a patient presenting with skin lesions for the past 3 weeks, associated with itching that worsens at night, starting as small erythematous papules or macules, then crusting and leaving hyperpigmentation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Scabies: Diagnosis and Treatment

Diagnosis

This clinical presentation is classic for scabies, characterized by the triad of pruritic skin lesions for 3 weeks, nocturnal worsening of itching, and progression from erythematous papules/macules to crusting with subsequent hyperpigmentation 1, 2.

Key Diagnostic Features

  • Intense nocturnal pruritus is virtually pathognomonic - itching that worsens at night and appears disproportionate to visible skin findings should immediately raise suspicion for scabies 1, 2.

  • Lesion evolution follows a characteristic pattern: initial erythematous papules or macules progress to excoriated lesions with crusting, ultimately leaving hyperpigmented areas after healing 2, 3.

  • Common distribution sites include finger webs, wrists, axillary folds, abdomen, buttocks, inframammary folds, and male genitalia - notably sparing the head in adults 2, 4.

  • Pathognomonic burrows (linear tracks up to 1 cm in length) confirm the diagnosis when present, though they may be difficult to identify due to excoriation 1, 2.

Confirmatory Testing

  • Microscopic examination of skin scrapings from burrows or papules demonstrating mites, eggs, or fecal pellets provides definitive diagnosis 2, 4.

  • Epiluminescence microscopy (dermoscopy) can visualize mites in vivo without requiring skin scraping 2.

  • Clinical diagnosis alone is acceptable when the history is characteristic (intense nocturnal pruritus, 3-week duration, typical distribution) and microscopy is unavailable 1.

Treatment

First-Line Pharmacologic Options

Treat with either topical permethrin 5% cream OR oral ivermectin - both have similar efficacy with clearance rates of 74% for permethrin versus 68% for ivermectin by week 2 5.

Topical Permethrin 5% Cream (Preferred for Most Cases)

  • Apply from neck down to entire body surface including under fingernails, leaving on for 8-14 hours before washing off 2, 5.

  • Repeat application after 7-14 days to eliminate newly hatched mites from eggs that survived initial treatment 2, 4.

  • Treatment failure occurs in 10.8% of cases, necessitating alternative therapy if symptoms persist beyond 2 weeks 5.

Oral Ivermectin (Alternative or for Special Populations)

  • Administer 200 mcg/kg as a single oral dose, repeated after 7 days 2, 4, 5.

  • Particularly indicated for: crusted scabies, immunocompromised patients, institutional outbreaks, and prophylaxis of close contacts 2.

  • Treatment failure rate is 11.8%, slightly higher than permethrin 5.

Adjunctive Symptomatic Management

  • Oral antihistamines (used in 91% of hospitalized cases) provide symptomatic relief of pruritus 3.

  • Topical corticosteroids may reduce inflammatory response but should not replace scabicidal therapy 3.

  • Oral antibiotics are indicated only when secondary bacterial superinfection is evident (present in 11% of cases) 3.

Critical Treatment Principles

All close personal contacts must be treated simultaneously, even if asymptomatic, as transmission occurs through prolonged skin-to-skin contact and the incubation period averages 10 days before symptoms appear 1, 2, 4.

Environmental decontamination is mandatory: launder all clothing, bedding, and towels used in the 3 days before treatment in hot water (≥60°C) and dry on high heat, or seal in plastic bags for 72 hours 2, 4, 5.

Pruritus may persist for 2-4 weeks after successful treatment due to ongoing hypersensitivity reaction to dead mites - this does not indicate treatment failure unless new burrows or lesions appear 2.

When to Refer

  • Diagnostic uncertainty after initial evaluation 1.
  • Patients under 2 months of age 1.
  • Failure to respond after two courses of different scabicides 1.
  • Crusted (Norwegian) scabies with hyperkeratotic plaques 1, 2.
  • Institutional outbreaks requiring coordination with local health protection services 1.
  • Sexually active patients should be screened for concurrent sexually transmitted infections 4.

Common Pitfalls

Do not delay treatment waiting for microscopic confirmation - the characteristic history of intense nocturnal pruritus with 3-week duration and typical lesion progression warrants empiric treatment 1, 2.

Do not confuse post-treatment pruritus with treatment failure - persistent itching for up to 4 weeks after successful eradication is expected and should be managed with antihistamines and topical corticosteroids, not repeated scabicides 2.

Do not treat the patient in isolation - failure to simultaneously treat household and intimate contacts accounts for most apparent treatment failures and reinfestations 2, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.